Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Reexamination of aspartoacylase: is this human enzyme really a glycoprotein?
[canavan disease]
Aspartoacylase
catalyzes
the
metabolism
of
an
important
amino
acid
in
the
brain
,
with
the
release
acetate
serving
as
the
source
for
fatty
acid
biosynthesis
.
Defects
in
this
enzyme
lead
to
a
loss
of
activity
and
the
symptoms
of
a
fatal
neurological
disorder
called
Canavan
disease
.
Extensive
evidence
,
including
deglycosylation
studies
,
differential
activity
upon
eukaryotic
host
expression
and
site
directed
mutagenesis
,
have
supported
the
presence
of
a
glycan
that
plays
an
essential
role
in
the
stability
and
catalytic
activity
of
mammalian
aspartoacylase
.
However
,
the
structure
of
this
enzyme
did
not
show
the
presence
of
any
non-amino
acid
components
at
the
putative
glycosylation
site
.
A
more
extensive
study
specifically
designed
to
resolve
this
discrepancy
has
now
shown
that
recombinantly-expressed
human
aspartoacylase
is
not
glycosylated
,
but
is
still
fully
functional
and
stable
even
when
produced
from
a
bacterial
expression
system
.
Alternative
interpretations
of
the
prior
experiments
now
present
a
consistent
picture
of
the
structural
components
of
this
essential
brain
enzyme
.
Diseases
Validation
Diseases presenting
"with the release acetate serving as the source for fatty acid biosynthesis"
symptom
canavan disease
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom